Verdacom introduces VerdaCore, a new subject randomization and drug supply management system built to service pharmaceutical and biotechnology clinical trials.
Online PR News – 02-June-2010 – – Princeton, NJ – Verdacom introduces its first product, VerdaCore, a new subject randomization and drug supply management system built to service pharmaceutical and biotechnology clinical trials.
Conceived and developed by clinical industry professionals with more than 20 years of clinical trial experience, VerdaCore is built as a robust, compliant, scalable and flexible platform for collecting and presenting clinical trial data.
"VerdaCore utilizes cloud computing and the power of agile software development to meet the fluid and time critical requirements of today’s increasingly complex clinical trials," said Daniel Scanlon, President of Verdacom. "VerdaCore is built using the latest tools and methodology for delivering secure, feature-rich, powerful, complex software solutions while meeting the rigorous compliance requirements of the pharmaceutical industry.”
VerdaCore is equipped with an number of features to service clinical trials of any size and complexity. Centralized subject randomization and drug supply inventory control provide the core components of the system. Role-based security controls the level of access to data, transactions and application tools. A centralized study contacts component maintains contact information online and is accessible by study team members, investigational sites and all vendors involved with the clinical trial. A shared calendar component details subject and inventory transactions in various calendar views and provides a unique way to view the progress of the trial. VerdaCore relies on graphical dashboards as a rich front-end for users, and dashboards are customized to show the most meaningful information for the trial at a glance.
VerdaCore is customized for each clinical trial using an internal end-to-end project quality management system, VerdaTrak. “VerdaTrak's primary focus is internal automated process management and tracking,” said Scanlon. “VerdaTrak allows our staff to centrally collect and store project information using an organized process, efficiently collaborate with teams, manage and track all project tasks and accurately track the status of all our ongoing projects.”
Scanlon, who first began developing randomization and drug distribution systems in the early 1990s, has reunited a dedicated team of professionals with extensive experience in clinical development, technology, regulatory requirements and global logistics. Scanlon holds that the combination of valued professionals and integrated randomization and drug inventory solutions will allow Verdacom's clients to effectively manage drug supplies, meet enrollment goals, reduce costly delays and track real-time trial progress.
Verdacom is a professional consulting firm providing subject randomization, drug supply management systems and project management services to the pharmaceutical and biotechnology industry. For more information, visit Verdacom's website at www.verdacom.com or contact Daniel Viglione at 954-320-6770 x202 or Daniel.Viglione@Verdacom.com.